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ABSTRACT
RNase H cleaves RNA in RNA–DNA duplexes. It is
present in all domains of life as well as in multiple
viruses and is essential for mammalian development
and for human immunodeficiency virus replication.
Here, we developed a sequencing-based method to
measure the cleavage of thousands of different RNA–
DNA duplexes and thereby comprehensively charac-
terized the sequence preferences of HIV-1, human
and Escherichia coli RNase H enzymes. We find that
the catalytic domains of E. coli and human RNase
H have nearly identical sequence preferences, which
correlate with the efficiency of RNase H-recruiting an-
tisense oligonucleotides. The sequences preferred
by HIV-1 RNase H are distributed in the HIV genome
in a way suggesting selection for efficient RNA cleav-
age during replication. Our findings can be used to
improve the design of RNase H-recruiting antisense
oligonucleotides and show that sequence prefer-
ences of HIV-1 RNase H may have shaped evolution
of the viral genome and contributed to the use of
tRNA-Lys3 as primer during viral replication.
INTRODUCTION
RNase H enzymes specifically hydrolyze RNA hybridized
to DNA (1) and are present in all domains of life. They are
essential for mammalian embryonic development (2,3) and
proteins with RNase H activity are also found in retroele-
ments and viruses, especially reverse transcribing viruses
such as Retroviridae, Hepadnaviridae or Caulimoviridae.
In these viruses, the RNase H activity helps remove the
RNA template from a newly synthesized DNA strand (4).
Humans have two enzymes exhibiting RNase H activity,
RNase H1 and RNase H2, which differ in their structure
and substrate specificity (5). RNase H1 is a monomer, com-
posed of a facultative mitochondrial targeting sequence,
a catalytic domain, a connection domain and a hybrid-
binding domain (HBD) and is required for mitochondrial
replication (6). RNase H2 is a heterotrimer and is, unlike
RNase H1, able to cleave at single ribonucleotides embed-
ded in DNA, which is crucial for preserving genome in-
tegrity (3).
Apart from these important cellular functions, theRNase
H enzymes are also essential for single-stranded oligonu-
cleotide therapeutics, which function by hybridization to
target RNA molecules, recruitment of RNase H and cleav-
age of the target RNA (7). Therapeutic RNase H-recruiting
oligonucleotides are often referred to as gapmers, because
they typically have a central DNA gap flanked by sugar
modified nucleotides, such as locked nucleic acids (LNAs)
and methoxyethyl (MOEs), to increase the binding affinity
to the target RNA. The requirement of RNase H1 for gap-
mer activity in vivo is supported by overexpression and de-
pletion experiments (8–10).
To optimize the design of therapeutic gapmers, param-
eters such as hybridization energy (11), toxic potential
(12,13), RNA secondary structure (14) and the existence of
off-targets (15,16), are analyzed in silico prior to experimen-
tal testing (17). Human RNase H1 is known to cleave cer-
tain sequences more efficiently than others (5), but the lack
of quantitative information on these preferences makes it
impossible to use them for gapmer design. Sequence pref-
erences of RNase H domains of retroviral reverse tran-
scriptases are better understood and are recognized to be
functionally important (18). Apart from general degrada-
tion of the RNA strand of its genome, human immunodefi-
ciency virus (HIV)-1 RNase H has to perform precise cleav-
ages around polypurine tracts (PPT) and at the last bond
of the tRNA-Lys3 primer during viral replication (19–21).
The fold of the catalytic domain of human RNase H1 is
remarkably similar to the fold of the Escherichia coli and
HIV RNase H catalytic domain (22), making it very dif-
ficult to develop specific HIV-1 RNase H inhibitors. Re-
cently, progress has been made, but so far no drug that
targets RNase H has made it to the clinic (23). Thus, an
improved understanding of the RNase H sequence prefer-
ences could facilitate both gapmer and antiviral drug de-
sign. Here, we present a novel method called RNase H
SequencePreferenceAssay (H-SPA), which we have used to
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comprehensively characterize sequence preferences of hu-
manRNaseH1,E. coliRNaseHI and theRNaseHdomain
of HIV-1 reverse transcriptase.
MATERIALS AND METHODS
Oligonucleotides used in the study
Names and sequences of all the oligonucleotides used in the
study are shown in Supplementary Table S2.
DNA–RNA–DNA/DNA duplex preparation
For the reverse transcription reaction, 500 pmol of oligonu-
cleotides R7 FS, R4A FS or R4B FS were mixed with 1
nmol of reverse transcription primer (DSP forR7 FS,DSP2
for R4A FS and R4B FS) in the presence of 1 mM Tris–
HCl pH 7 and 0.1 mM ethylenediaminetetraacetic acid
(EDTA) in the volume of 100 l and heated to 65◦C for
5 min, followed by incubation at 21◦C for 5 min and subse-
quently kept on ice. Next, 100 l of enzyme-mix was pre-
pared by mixing four volumes of 5× PrimeScript buffer,
four volumes of H2O, one volume of PrimeScript reverse
transcriptase (Takara) and one volume of 10 mM dNTP
mix and added to the template-primer mixture, followed
by incubation at 42◦C for 30 min and transfer to ice. Re-
actions were stopped by addition of 50 l 50 mM EDTA
and 250 l native elution (NE) Buffer (20 mM Tris–HCl
pH 7.5, 20 mM KCl and 1 mM EDTA) and concentrated
down to∼75l usingAmiconUltra 3Kfilter devices (EMD
Millipore). Electrophoresis loading buffer (15 l; 10 mM
Tris–HCl pH 7.5, 60% glycerol and 60 mM EDTA) was
added to the samples, which were loaded on 20% native
polyacrylamide gel (Acrylamide/Bis-acrylamide= 19:1; 1×
Tris/Borate/EDTA (TBE); two lanes for each sample) and
run for 21 h at constant voltage (150 V). The samples were
visualized with blue-light transiluminator and the dom-
inant bands (corresponding to DNA–RNA–DNA/DNA
duplex) were cut out, crushed, soaked with 500 l NE
buffer, frozen at −80◦C for 10 min and incubated overnight
at 21◦C with constant shaking (1000 rpm) in the presence
of 200 l phenol. Following elution from the gel, the buffer
was extracted with chloroform, concentrated on Amicon
Ultra 3K filter devices (elution from the second band added
to the same filter unit and centrifuged again) and further
purified on illustra S-200HR column (GE Healthcare) pre-
equilibrated with NE buffer. The duplex structure of the
representative substrate preparations was confirmed using
native 20% electrophoresis by comparing to non-hybridized
and hybridized oligonucleotides and DSP primer (but not
reverse transcribed). Finally, concentration of each duplex
was adjusted with NE buffer to 0.1 absorbance units at 260
nm with 10 mm path (which is approximately equivalent to
0.1 M).
Duplex hydrolysis with RNase H enzymes
Hydrolysis reactions with recombinant human RNase H1
(Creative BioMart cat. RNASEH1-433H) were performed
at 37◦C in a buffer RNH1 (20mMTris–HCl pH 7.5, 20mM
KCl, 20 mM 2-mercaptoethanol, 2 mMMgCl2 and 0.1 mM
EDTA (modified fromLima et al., 2001 (24)). Preheated so-
lution containing 0.3 pmol of prepared duplex in 16.5 l
was mixed with preheated 16.5 l of 0.5 mU/l RNase H1
dilution to initiate the hydrolysis reaction to give a final en-
zyme concentration of 0.25 mU/l. After 10 min, reactions
were terminated by transferring them into a tube containing
160 l precipitation mix (375 mM NaOAc pH 8, 1.25 mM
EDTA and 62.5 ng/l glycogen) and 200 l phenol and
vigorously shaking. Reactions were chloroform extracted,
ethanol precipitated and resuspended in 10 l TE (pH 7)
buffer, out of which 2 l were mixed with 10 l formamide
loading buffer (10 mMEDTA in formamide), resolved with
denaturing polyacrylamide (8% PAA, 7M Urea, 1× TBE)
electrophoresis and visualized using Typhoon FLA 7000
scanner (GE Healthcare; detection of 6-carboxyfluorescein
(FAM) fluorescence). Reactions with E. coliRNase H from
Thermo Scientific (cat. EN0201) were performed at 37◦C
in a buffer composed of 50 mM Tris–HCl pH 8.3, 75 mM
KCl, 3mMMgCl2, 10mMdithiothreitol (DTT), 0.4mg/ml
bovine serum albumin and 0.1 mM EDTA using the same
protocol as for the reactions with human-derived enzyme,
but with a final enzyme concentration 0.5 mU/l. Reac-
tions with HIV-1 Reverse Transcriptase from Worthington
Biochemical Corporations (cat. LS05003) were performed
as humanRNase H1, with the final concentration of the en-
zyme 0.1U/l. Control hydrolysis reactions labeled ‘EDTA’
were performed using identical conditions, but in the pres-
ence of 10mMEDTA,whereas control reactions performed
in ‘cold’ conditions were incubated for 30 min at 16◦C.
Sequencing library construction
RNase H-hydrolyzed samples (5 l in total; some samples
combined at this step) were mixed with 5 l of 0.4 MRTP
primer and reverse transcribed using the same protocol as
used for duplex preparation (volumes scaled down 10×).
A total of 5 l of the reverse transcription (RT) reaction
was used as a template for polymerase chain reaction (PCR)
amplification with Phusion polymerase (New England Bio-
labs), RP1 and RPIx primers (x corresponds to index num-
ber) performed in 50 l volume with thermal cycling pro-
tocol of (98◦C for 3 min), (98◦C for 80 s; 60◦C for 30 s;
72◦C for 15 s) × 8, (72◦C, 10 min; 4◦C, hold). The PCR
reactions were quantified with the Bioanalyzer DNA 1000
kit (Agilent Technologies) on an Agilent 2100 Bioanalyzer,
pooled in the presence of the excess of EDTA and Ampure
XP purified (Beckman Coulter). The prepared library was
sequenced on an Illumina HiSeq Rapid Flow Cell (1 × 50
bp protocol).
RNase H cleavage assays
The designed RNase H cleavable substrates (One of FAM-
labeled oligonucleotides: gapR4b der1, gapR4b der2,
gapR4b der3 or one of Cy5 labeled oligonucleotides:
gap O1 der3 Cy5; gap O5 der3 Cy5) were mixed with
10-fold excess of complementary DNA in 1× annealing
buffer (20 mM Tris–HCl pH 7.5, 20 mM KCl, 20 mM
2-mercaptoethanol; RNA containing strand = 0.2 M,
DNA complement = 2 M). The mixtures were incubated
at 95◦C for 2 min, transferred to 55◦C for 10 min and to
Downloaded from https://academic.oup.com/nar/article-abstract/45/22/12932/4602871
by Faculty of Life Sciences Library user
on 02 February 2018
12934 Nucleic Acids Research, 2017, Vol. 45, No. 22
30◦C for 10 min, before 0.5 volume of 1× Mg-annealing
buffer (20 mM Tris–HCl pH 7.5, 20 mM KCl, 20 mM
2-mercaptoethanol and 6 mMMgCl2) was added, followed
by incubation at 30◦C for 10 min and transfer to ice.
These annealed duplexes were mixed with another duplex
(prepared in the same way), but labeled with different
fluorophore. The combined duplexes were pre-heated for
10 min at 30◦C, mixed with an equal volume of 2 mU/l
human RNase H1 in RNH1 buffer (preheated to 30◦C).
Reactions were terminated at time points: 10 and 40 min
by transferring 30 l reaction to an equal volume of
formamide-EDTA (99% formamide and 5 mM EDTA).
The setup of the undigested control reaction was identical,
but with RNH1 buffer instead of enzyme. The hydrolysis
reactions were heat denatured (95◦C, 2 min; transferred on
ice) and resolved on 15% polyacrylamide, 7M Urea, 1×
TBE gel and visualized on Typhoon FLA 7000 scanner
(detection of Cy5 followed by detection of FAM). Signal
intensities of different bands were background subtracted
and quantified using ImageJ software. Results of 40 min
incubation are presented in the manuscript.
Hydrolysis of duplexes using molar excess of the human
RNase H1 enzyme was performed as described above ex-
cept: (i) the annealed duplexes were not mixed with a ref-
erence substrate; (ii) the final enzyme concentration was 4
U/l (∼7× molar excess over the duplex in this experi-
ment); (iii) the hydrolysis reactions were assembled in the
cold room using pre-chilled pipette tips and incubated for 5
s at 4◦C, before theywere terminated by addition of an equal
volume of urea stop solution (8MUrea, 1× TBE and 5mM
EDTA); (iv) the reactions were denatured and resolved on a
10 well Novex™TBE–Urea gel (15%) and the gel was visual-
ized with the ChemiDoc Touch Imaging System (Bio-Rad)
using a Blue Tray.
Cleavage assays with nicked dumbbell inhibitors
RHase H hydrolysis reactions were performed with ei-
ther substrate A (gapR7 der3 + gapR7 der3 Cy5) or sub-
strate B (gapR4b der3 + gapR4b der3 Cy5). Each sub-
strate was a mixture of two RNA-containing strands with
two different fluorophores (FAMor Cy5). Oligonucleotides
were mixed with 10-fold excess of complementary DNA
(gapR7 der3 comp or gapR4b der3 comp) in 1× anneal-
ing buffer (20 mM Tris–HCl pH 7.5, 20 mM KCl, 20 mM
2-mercaptoethanol; RNA containing strand with FAM =
0.1 M,RNA containing strand with Cy5= 0.1 M,DNA
complement = 2 M), incubated at 95◦C for 2 min, trans-
ferred to 55◦C for 10 min, transferred to 30◦C for 10 min,
added 0.5 volume of 1×Mg-annealing buffer (20 mMTris–
HCl pH 7.5, 20 mM KCl, 20 mM 2-mercaptoethanol and
6 mM MgCl2), incubated at 30◦C for 10 min and trans-
ferred on ice. Nicked dumbbells (gapR4b der1 nickcirc and
gapR4b der2 nickcirc) were prepared by mixing 8 l of 10
M oligonucleotide, 2.5 l 10× annealing buffer and 14.5
l H2O. They were incubated at 95◦C for 2 min and trans-
ferred on ice. A total of 12.5 l 1× Mg-annealing buffer
was added. Serial dilutions of the nicked dumbbells were
prepared by diluting 6× with equal volume of a dilution
buffer (10 l 10× annealing buffer, 90 l H2O and 50 l 1×
Mg-annealing buffer). The no-dumbbell control was only
dilution buffer. For the cleavage reactions, 7.5 l of the sub-
strate A or substrate Bwasmixedwith 7.5l of a dilution of
one of the nicked dumbbells, yielding 32 reactions in total.
Human RNase H1 was diluted to 5 mU/l in 10× RNH1
buffer. Equal volumes (15 l each) of the substrate-nicked
dumbbell and of the RNase H1 dilution (both preheated to
30◦C) were combined and incubated for 40 min, before the
reactions were terminated by addition of 30 l formamide-
EDTA. Samples were gel analyzed as described above. For
the dumbbells design, previously described stable terminal
tetraloops were utilized (25).
Data pre-processing
The raw sequencing reads were filtered to contain only those
that perfectly matched the sample index (default illumina
processing workflow allows for single mismatch, which we
have noticed slightly decreased our data quality). The data
from pooled samples prepared with DSP (R7) and DSP2
(R4a, R4b) primers were divided using the cutadapt utility
(26) by matching the sequence immediately after the ran-
domized part of the constructs (12% error rate allowed,
with quality filtering ‘–q 20’) and requiring the preceding
sequence to match the length of the designed randomized
fragment. Using an awk script, the reads containing am-
biguous nucleotides ‘N’ in the randomized fragment or not
matching the design of the library, were removed (e.g. if the
designed fragment contained S nucleotides at a given po-
sition, all reads having A or T there were discarded). In
the R7 experiment for the HIV-1 enzyme, we found no re-
producibility of the counts of the sequencing reads starting
with the sequence ‘ATTA’ and all the reads starting with this
tetramerwere left out of the analysis. Next, a shell script was
used to split the sequences into 1–8 nt long stretches starting
at each possible position of the randomized fragment and
the number of occurrences of unique sequence was counted.
The data frames containing these raw counts were read into
R (27) to perform the subsequent data analysis.
Calculation of log2 fold changes from the sequencing data
Fold-changes of different motifs were calculated by com-
paring the fractions of a given k-mer at a given position
within the assayed construct before and after RNase H
treatment (across replicates), using edgeR package (28).
This analysis takes the advantage of the count nature of the
dataset and models the dispersion based on the observed
data. See Supplementary Data for the full list of samples
used for the calculations.
Prediction of log2 fold changes for human RNase H1. To
predict the log2 fold change of a hexamer using the single
nucleotide model, we first calculated the position-specific
log2 fold changes of single nucleotides (see above), and then
we summed the log2 fold changes for the nucleotides, which
made up a given hexamer. For the dinucleotide model, a
similar procedure was used, but before summing the log2
fold changes of the dinucleotides that made up a given hex-
amer, they were multiplied by 0.5 to adjust for the fact that
a given nucleotide is covered by two dinucleotides. Likewise,
the flanking dinucleotides were multiplied by 0.75 to correct
for one of the positions being part of two dinucleotides.
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Prediction of log2 fold changes for HIV-1 RNase H. To
model sequence preferences of the HIV-1 RNase H, each
heptamer was associated with two values: preferred cleav-
age position and the observed cleavage extent. First, the log2
fold changes of each possible heptamer sequence were cal-
culated for each of the seven possible locations within the
R7 construct. Assuming that heptamers are cleaved most
efficiently when located central in the RNA part of the R7
construct (as we observe for GCGCAA), the preferred lo-
cation of cleavage can be assigned using the following al-
gorithm. For ∼70% of the heptamers, we find that the two
most downregulated heptamer locations within R7 were
neighboring. If the strongest downregulation was observed
for a given heptamer starting at positions 1 and 2 of R7,
then preferred cleavage site within the heptamer was as-
signed to be after nucleotide 7. If the strongest downregula-
tion was observed for a given heptamer starting at positions
2 and 3 of R7, then preferred cleavage site within the hep-
tamer was assigned to be after nucleotide 6. Likewise, if the
strongest downregulationwas observed for heptamers start-
ing at positions 3 and 4, 4 and 5, 5 and 6 or 6 and 7, then
preferred cleavage site within the heptamer was assigned
to be after nucleotide 5, 4, 3 or 2, respectively. If the two
most downregulated locations were not neighboring, only
the most downregulated was considered––and the cleavage
site was assigned after 8-n (for n being the most downregu-
lated position) nucleotide. To calculate the observed cleav-
age extent, the value of the position having themost efficient
downregulation was used.
Calculation of relative processing rate constants (krel)
The relative processing rate constant (krel) is defined as a
ratio of kcat/Km of a compound of interest to the refer-
ence compound. The use of krel for analysis of enzymatic
reactions withmultiple competing substrates has previously
been described Guenther et al. (29). Here, we have calcu-
lated krel by comparing the processing rate to the average
processing rate observed in our pool of substrates rather
than to a specific sequence. To calculate krel for a given nu-
cleotide at a given position for each of the three sequenced
constructs, krel value for nucleotide i was calculated accord-
ing to:
krel, i = log (FCi ∗ (1 − f ))
log (1 − f )
Here, FCi is a fold change of a given nucleotide as calculated
using edgeR and f is a cleaved fraction of the pooled duplex
as quantified from scans of the gel. Since the analysis used
replicates to estimate FC’s, the value of f is an average of the
replicates.
Values of krel for substrates relative to the reference com-
pound were calculated according to:
krel, = log (1 − fsub)
log (1 − fref )
Here, fsub is a cleaved fraction of a substrate of interest and
fref is a cleaved fraction of a reference substrate.
Comparison with RNA knockdown data
The knockdown efficiencies of microtubule-associated pro-
tein tau (MAPT) (ENSG00000186868) and ANGPTL3
(ENSG00000132855) after treatmentwith the different gap-
mers were extracted from the published patents (30,31). For
MAPT, we used the data from the SH-SY5Y cell line trans-
fected using electroporation with 8 M gapmer and hav-
ing a 5-8-5 design. For ANGPTL3, knockdown efficien-
cies originated from the HepG2 cell line transfected using
electroporation with 4.5 M gapmers with a 5-10-5 design.
In addition, only gapmers having a perfect reverse comple-
mentary match to the relevant pre-mRNA were used in the
analysis. For the ANGPTL3 dataset, many gapmers have
too low affinity to function efficiently (11) and we there-
fore only used the data obtained with gapmers having six
or more G or C nucleotides for the analysis. When a gap-
mer was tested in replicates, the results from the individual
replicates were averaged and included once for the corre-
lation analysis. Knockdown data were compared with hu-
man RNase H1 cleavability predictions based on the results
of the R4b construct probing, considering 8 dinucleotides
starting from position 7 of the randomized gap
Mapping cleavage scores to viral genomes
Each heptamer in the viral genome was modeled to direct
cleavage to a particular bond with an associated cleavage
efficiency (based on the HIV-1 RNase H model described
above). Some bonds were not modeled to be cleaved at all, if
all heptamers in their vicinity directed the cleavage to other
bonds. When multiple heptamers directed cleavage to the
same position, the minimal cleavage score (corresponding
to the most efficient cleavage) was assigned.
Random sampling of the viral genomes
The HIV-1 (GenBank: K03455.1), HIV-1 vector pNL4-
3 (GenBank: AF324493.2, positions 1-9709) and HIV-2
(GenBank: KX174311.1) genomes were randomly sampled
while statistically preserving the local dinucleotide content.
For each sampled position, a dinucleotide was randomly
selected so that: (i) its first nucleotide matches the last nu-
cleotide of the preceding dinucleotide [does not apply to the
first dinucleotide] and (ii) sampling probabilities are propor-
tional to the counts of the dinucleotides in the local, 65 nt
wide window centered on sampled dinucleotide. The pro-
cedure was repeated 10 000×, followed by mapping cleav-
age scores to viral genomes (see above) and calculating dis-
tances between nearest 10% best cleaved bonds.
RESULTS
RNase H sequence preference assay (H-SPA)
In the H-SPA method, an engineered DNA duplex carry-
ing a central randomized cleavable RNA–DNA sequence
(Figure 1A) is subject to limited digestion with RNase H.
The fixed flanks of the construct allow subsequent quan-
tification of the uncleaved molecules by massive parallel se-
quencing (Figure 1B). We used three different construct de-
signs to evaluate the effect on the enzyme’s sequence pref-
erences (Figure 1A). Constructs R4a and R4b contain a
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Figure 1. Overview and validation of the H-SPA method. (A) Sequences
of the cleavable randomized gaps used in this study. (B) Schematic repre-
sentation of the experimental strategy. (C) Denaturing gel electrophoresis
showing the limited digestion of double stranded substrates. The uncleaved
duplexes are indicated with the asterisk and the cleaved fragment with the
tilde. The reaction conditions are indicated: w: 37◦C; c: 16◦C and EDTA:
0.1 mM. (D) Correlation of heptamer counts for the construct R4b (posi-
tions 9–15) between two untreated controls (top left), two human RNase
H1 treated samples (top right) and a control and a treated sample (bot-
tom).
central stretch of four ribonucleotides flanked by 2′-O-Me
modified nucleotides, thereby restricting hydrolysis to one
specific position (22,32). The 2′-O-Me modified nucleotides
block cleavage and have a preference for C3′-endo pucker-
ing at the cleaved strand (33,34) similar to the structure of
RNA in a regular RNA–DNA hybrid. The R7 construct
contains a stretch of seven ribonucleotides flanked by DNA
and is therefore more similar to native RNase H substrates,
but can be cleaved at several different positions. After lim-
ited cleavage with three type 1 RNases H enzymes: human
RNase H1, E. coli RNase HI and RNase H of the HIV-1
reverse transcriptase (Figure 1C and Supplementary Figure
S1) followed by massive parallel sequencing, we compared
counts of k-mers at the same position of the randomized se-
quence between control and treated samples. We observed
a very high correlation between replicated controls and be-
tween replicated cleaved samples, whereas the correlation
between control and cleaved samples was reduced (Figure
1D). This demonstrates that the H-SPA method is highly
reproducible and accurately quantifies the cleavage of dif-
ferent sequences in our duplex libraries. The decreased cor-
relation between control and cleaved samples shows that the
RNase H treatment results in the biased hydrolysis of dif-
ferent sequences (P-value ∼ 0 for difference between corre-
lation coefficients; Fisher r-to-z transformation).
Sequence preferences of different RNase H enzymes
To better understand the sequence preferences of the three
RNase H enzymes, we used our sequencing data to deter-
mine the (i) position-specific changes in nucleotide content
after RNase H treatment, (ii) importance (information con-
tent) of different positions of the recognized sequence and
(iii) best-cleavedmotifs (Figure 2A and Supplementary Fig-
ure S2a). The sequence preferences of the E. coli and hu-
man enzymes are nearly identical. Both enzymes efficiently
cleave the RNA strand in the sequence context CA↓AG
and prefer a G-rich sequence upstream of the cleavage site.
Importantly, for each enzyme the observed preferred se-
quences are very similar for the three different duplexes
tested, demonstrating that they are not dependent on the
context of the specific constructs and that H-SPA is repro-
ducible. The HIV-1 RNase H yielded a different sequence
preference than the human and E. coli enzymes (Figure 2A
and Supplementary Figure S3) and did not efficiently cleave
the R4b construct (Supplementary Figure S1). In the case
of all three enzymes, our data demonstrate that they exhibit
clear sequence preferences. This supports the notion pre-
viously observed for E. coli RNase P that even apparently
non-specific nucleic acid-interacting enzymes display inher-
ent specificity when studied in-depth (29).
To validate the observed preferences of the humanRNase
H1, we synthesized three duplexes with the sequences found
to be the most preferred, the most avoided or the closest to
the average for cleavage by the RNase H, respectively (Sup-
plementary Figure S4). A convenient metric to compare ki-
netics of enzymatic reaction with internal competition is a
relative processing rate constant (krel), described in ‘Ma-
terials and Methods’ section. In agreement with our pre-
dictions, the ‘preferred’ substrate was cleaved considerably
more efficiently and the ‘avoided’ less efficiently than a ref-
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Figure 2. Sequence preferences ofEscherichia coli,Homo sapiens andHIV-
1 RNase H (A) The heatmaps display the changes in nucleotide composi-
tion at different positions for the R7 construct (left) and the R4b construct
(right) after cleavage with the three different RNase H enzymes. The inten-
sity of the red and blue color indicates the krel of having given nucleotide
at a given position fixed relative to the average hydrolysis rate of the ran-
domized pool. The barplots below the heatmaps show the overall informa-
tion content at each position and the sequence logos are based on the 1%
most downregulated pentamers. Note that only the randomized parts of
the probed duplexes is displayed. (B) Cleavage of sequences predicted to
be preferred (‘P’), avoided (‘A’) and neutral (‘N’) with respect to cleavage
with human RNase H1 compared to the cleavage of a reference substrate.
With respect to the reference substrate, the krel of the preferred substrate
is 3.7, of the avoided is 0.26 and of the neutral it is 1.4. (C) The design
of the dumbbell substrate mimics. The gray box indicates the region hav-
ing either the preferred (‘P’) or avoided (‘A’) sequence. (D) The cleavage
of a reference substrate in the presence of increasing concentrations of a
preferred or avoided dumbbell substrate mimic.
erence, whereas the extent of the cleavage of a ‘neutral’ sub-
strate was close to the reference (Figure 2B and Supplemen-
tary Figure S2b). Unexpectedly, the overall amount of hy-
drolyzed material was reduced in the reaction with the ‘pre-
ferred’ substrate, indicating that it stays associated with the
enzyme longer than the other two substrates either by hav-
ing a higher melting temperature (Supplementary Table S1)
or because of amore energetically favorable inter-molecular
interaction with the enzyme (Supplementary Discussion).
We therefore tested nicked dumbbell versions of the pre-
ferred and avoided substrates, designed in such a way that
the cleaved strand cannot dissociate from the duplex (Figure
2C). We find that the hydrolysis of a reference substrate in
the presence of the ‘preferred’ nicked dumbbell is potently
inhibited, whereas the ‘avoided’ nicked dumbbell has a neg-
ligible effect (Figure 2D and Supplementary Figure S2c),
indicating that the preferred substrate has high affinity for
the enzyme and this could be the molecular basis for both
the efficient cleavage of this sequence and its ability to in-
hibit the cleavage of the reference sequence.Moreover, when
using a molar excess of enzyme over the substrates (Supple-
mentary Figure S2d), we find that the ‘preferred’ substrate is
cleaved more efficiently than the ‘avoided’ substrate, which
supports ourH-SPA findings and the interpretation that the
‘preferred’ substrate can cause product inhibition.
Sequence preference model for human RNase H1
To further validate our data and explore the importance of
the Human RNase H1 sequence preferences, we used our
comprehensive dataset for duplex R4a to construct a po-
sition weight matrix (PWM), which for each nucleotide at
each position quantifies the relative concentration change
after RNase H cleavage of the subset of molecules hav-
ing this nucleotide at this position change (Supplementary
Data). Using the PWM constructed from the result of the
R4a experiment to predict the outcome of the R4b exper-
iment, we can explain 69% of the changes occurring (Fig-
ure 3A). Interestingly, the predictive power increased to 78%
whenwe constructed amodel based on dinucleotide content
and used this to predict the R4b experiment outcome (Fig-
ure 3B). This finding suggests that features such as stacking
or bending of the duplex, which are affected by dinucleotide
dependencies, are involved in RNase H1 cleavage efficiency.
More complex models using 3, 4 or 5 nt words as the input
did not lead to further improvements in the performance of
the prediction (Supplementary Figure S5), indicating that
long-range dependencies for the substrate recognition by
the RNase H1 catalytic domain are negligible. To further
validate the predictive power of the dinucleotide model for
humanRNaseH1,we predicted cleavage of theDNA/RNA
duplex that was used to crystallize the catalytic domain of
humanRNaseH1 (Figure 3C) (22).When requiring the pre-
viously reported interaction with 11 bp of the duplex, we
find that out of the eight possible interaction modes, RNase
H1 contacts the enzyme at exactly the position predicted to
have the highest preference for cleavage (Figure 3C). Since
the structure was solved using a catalytic deficient mutant,
this result supports the idea that the RNase H sequence
preferences at least partially depend on the binding of the
duplex substrate.
RNase H1 is central to the therapeutic action of gap-
mers and we therefore wanted to investigate whether our
sequence preference model could predict gapmer potency.
We used two large published datasets of in vitro activity
screening of gapmers targeted against different positions of
the MAPT (30) and Angiopoetin-like 3 (ANGPTL3) (31)
mRNAs. For the target site of each of the gapmers tested
in these studies, we calculated the predicted cleavage us-
ing the H-SPA 9 nt wide dinucleotide model and compared
this value to the observed reduction of mRNA level. For
both the MAPT and ANGPTL3 knockdown experiments,
we find a similar correlation pattern. The predictions for po-
sitions in the central part, which can be cleaved by RNase
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Figure 3. RNase H Sequence Preferences correlate with gapmer efficiency.
(A) Correlation between the log2 fold changes of different hexamers ob-
served for the R4b construct in the experiment and the corresponding log2
fold changes as predicted by a single nucleotide model prepared from the
data obtained in the R4a experiment. (B) As in (A), but with prediction
with a dinucleotide model. (C) Prediction of RNase H1 mediated down-
regulation of the different 11-mers present in RNA sequence used for the
RNase H RNA–DNA heteroduplex crystal structure [PDB: 2QK9]. Each
bar corresponds to the cleavage site of a potential binding mode of RNase
H1. The filled bar corresponds to the RNase H1 binding mode observed
in the crystal structure and is also indicated in the drawing below the plot.
(D) Correlation between the change of target RNA level for MAPT (30)
after treatment with 1518 different gapmers and the corresponding down-
regulation predicted by the dinucleotide model for the different binding
modes ofRNaseH1 on each gapmer target duplex. The error bars show the
99% confidence intervals. The drawing below the plot indicates the RNase
H1 binding mode associated with the best-observed correlation. (E) The
same analysis as in (D), but with 1581 different gapmers targeted against
ANGPTL3 (31).
H, significantly correlated with the observed gapmer activ-
ity, but predictions for the flanks, which cannot be cleaved,
did not (Figure 3D and E), indicating that the H-SPA dinu-
cleotide model has the potential to improve gapmer design.
Sequence preference model for HIV-1 RNase H
The HIV-1 RNase H enzyme activity of the viral reverse
transcriptase is essential for the viral life cycle, but so far
it has not been possible to make a general prediction of
cleavage positions in the viral genome. In our HIV-1 exper-
iment, we observe that the fold changes of different RNA
heptamers had a non-Gaussian distribution (Figure 4A),
showing that the HIV-1 enzyme has distinct sequence pref-
erences for cleavage. This agrees with the findings from a
previous study, which analyzed a limited number of se-
A
B
C
Figure 4. Refining the HIV-1 RNase H sequence preference model. (A)
Distributions of the observed log2 fold changes of RNA heptamers in R7
for human RNase H1 (right) and HIV-1 RNase H (left). (B) The observed
log2 fold changes after cleavage with HIV-1 RNase H for an efficiently
cleaved hexamer (GCGCAA) located at different positions of R7. The po-
sition of the arrow indicates the cleavage site as aligned to the picture of
scissors in the box and the arrow length represents the efficiency of cleav-
age. (C) Sequence logos of the best cleaved quartile of sets of heptamers
predicted to have the same cleavage site. The arrows indicate the predicted
cleavage site, with the length proportional to the observed cleavage effi-
ciency.
quences for in vitro cleavage efficiency by HIV-1 RNase H
(18), but our dataset allows a much more comprehensive
characterization of the sequence preferences (Figure 2A and
Supplementary Figure S6). For the HIV-1 enzyme, we only
observed efficient cleavage of the construct with the seven
RNA positions, which allows the HIV-1 RNase H to cleave
at several different positions, thereby making the interpre-
tation of the results more difficult. We therefore reasoned
that the sequence preferences observed in Figure 2A could
be further improved by aligning sequence words by their
position of cleavage. First, we aligned the hexamer (‘GCG-
CAA’), which is cleaved between its last 2 nt (18), at differ-
ent positions of the R7 substrate, and noted that the level
of downregulation depended on the location (Figure 4B).
For optimal cleavage of this motif by HIV-1 RNase H, at
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least four ribonucleotides upstream and at least two ribonu-
cleotides downstream of the cleavage site are required. In
addition, we find that having less than three ribonucleotides
upstream of the cleavage site completely inhibits the cleav-
age.Understanding these requirements, we could assign two
values to each heptamer sequence, one describing the effi-
ciency of cleavage and another describing at which bond the
heptamer was predominantly cleaved (for details see ‘Mate-
rials and Methods’ section; for values see Supplementary
Data). This allowed us to split all the heptamers into seven
groups depending on the cleavage location. For each set, we
used the most downregulated quartile to create sequence lo-
gos (Figure 4C). The logos from the different groups largely
resemble each other when aligned by the assigned cleavage
location. The analysis shows that the preferred sequence rel-
ative to the cleavage site is (C/G) at −5, (C/G/U) at −4,
(C/G) at −2 and (A/U) at −1 and +1; the most important
positions within the assayed region are −5, −4, −2 and +1,
agreeingwith the results obtained by the evaluation of a lim-
ited number of single sequences (18).
Functional significance of HIV-1 RNase H sequence prefer-
ences
To learn more about the function of HIV-1 RNase H in the
viral lifecycle, we assigned RNase H cleavage scores to each
bond in the HIV-1 genome (Figure 5A). In HIV-1 replica-
tion, the reverse transcription of the DNA minus strand
is primed with human tRNA-Lys3 at the primer binding
site (PBS) of the viral RNA genome (35). The newly syn-
thesized minus strand DNA fragment is transferred to the
RNA genome’s 3′ end and DNA minus strand synthesis is
continued (Figure 5B). The HIV-1 RNase H is responsible
for degradation of the HIV-1 RNA genome upon synthesis
of theDNAminus strand. Biochemical experiments suggest
that after the initial nicking concurrent withDNApolymer-
ization, the genomic RNA degradation predominantly oc-
curs by RNA 5′-end-directed cleavage with cleavages occur-
ring about 18 nt from the RNA 5′ end (36) and in a progres-
sive manner with the 5′ end created by the previous cleavage
facilitating the next cleavage (37). We therefore calculated
the distances between sites in the HIV-1 genome that were
predicted by H-SPA to be well cleaved. Strikingly, we find
that HIV-1 has a highly significant over-representation (P
< 10−5) of well-cleaved sites separated with a distance of
13–19 nt, as compared to the cleavage distances we obtain
when we repeatedly perform the same analysis on random-
ized versions of the HIV-1 sequence that preserve the local
dinucleotide content (see ‘Materials and Methods’ section)
(Figure 5C and Supplementary Figure S7a). This finding
supports that degradation of the HIV-1 RNA occurs by a
5′-end-directed mechanism and indicates that there is a se-
lective pressure for the HIV-1 genomic sequences to be effi-
ciently cleaved by the viral RNase H.
During minus-strand DNA synthesis, HIV-1 RNase H
is known to cleave specifically at the 5′ and 3′ ends of the
cleavage-resistant 3′PPT region, which forms a primer for
the plus-strand DNA synthesis. H-SPA predicts the precise
location of specific cleavage at the 5′ end of the PPT (21)
(Figure 5D, bond 9064), but not the 3′ cleavage (Figure 5D;
bond 9083). This is in agreement with the 3′ cleavage being
precise, but not kinetically favored (19) and the PPT adopt-
ing an untraditional structure with the base pairing out of
register (38), which is unlikely to be recaptured in our as-
say. The plus-strand DNA is synthesized from the 3′PPT
primer and forms local RNA–DNA hybrid with tRNA-
Lys3 primer located at the DNA minus strand terminus
(Figure 5B). The tRNA primer is cleaved by HIV-1 RNase
H at the last bond of the tRNA, leaving rA at the 5′ end
of the (−)DNA strand (20), which is essential for the plus-
strand transfer to occur (39) and facilitates the integration
process (40). According to the sequence preferences deter-
mined by H-SPA, cleavage at the last bond is indeed the
most preferred location within the tRNA 3′ terminal 18 nt
(Figure 5E). The last part of the RNA genome to be reverse
transcribed is the PBS, which remarkably contains the se-
quence predicted to be the fifth best RNase H-cleavage site
within the entire HIV-1 genome (Figure 5F). Clearing the
DNA minus strand complement of the PBS from any hy-
bridized RNA fragments is necessary to allow plus-strand
DNA transfer to take place during viral replication (Fig-
ure 5B) and we therefore propose that the presence of this
previously unrecognized efficient cleavage site in the PBS se-
quence is important for the HIV-1 life cycle. Since the PBS
is the reverse-complement of the tRNA primer, our findings
show that compared to other human tRNAs and their po-
tential PBSs (41), the tRNA-Lys3 sequence is the best sub-
strate for RNase H cleavage in both directions (Figure 5G).
DISCUSSION
We present the H-SPA method, which allows comprehen-
sive mapping of RNase H sequence preferences by detect-
ing changes in frequencies of specific sequences after RNase
H cleavage within a randomized pool of RNA–DNA sub-
strates. Conceptually, our strategy resembles the strategy
previously used to detect the sequence preference of RNase
P (29), but in our method, we have introduced a double
stranded substratewith amixed chemistry and increased the
length of the randomized gap.
To deal with the increased sequence complexity of our ex-
perimental set-up, which exceeded the number of obtained
sequencing reads, we also developed a novel data analy-
sis approach focusing on enrichment of k-mers at specific
positions of the randomized sequence. The computational
strategies and methods developed for H-SPA data analy-
sis use robust count-based RNA-seq analysis (28), which
explicitly takes experimental variability into account and
could be adapted for the analysis of other types of SPAs. To
ensure the reproducibility and to facilitate future studies, we
have implemented and released anR package ‘spaseq’ and a
vignette illustrating each step of the data analysis workflow
(see ‘Materials and Methods’ section).
Using H-SPA, we comprehensively characterized se-
quence preferences of three type 1 RNase H enzymes from
phylogenetically distant hosts: human RNase H1, E. coli
RNase HI and RNase H domain of HIV-1 reverse tran-
scriptase. We were particularly interested in the prefer-
ences of the human enzyme, which is necessary for gapmer-
mediated target knockdown (8–10) and therefore influences
the pharmaceutical activity of an entire class of human
drugs. We demonstrate that human RNase H prefers to
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Figure 5. Functional significance of predicted HIV-1 RNase H cleavage sites. (A) Predicted RNase H cleavage efficiency of the HIV-1 genome, shown as
log2(fold change) (log2FC). (B) Schematic of theHIV reverse transcription.White scissors at the black circle indicate specific areas zoomed-in in subsequent
panels. (C) Comparison of distances (in nucleotides) betweenwell-cleaved sites in theHIV-1 genome and in the randomizedHIV-1 genomes. The red rhombi
shows the observed count of distances between positions predicted to be efficiently cleaved in HIV-1 genome that fall into the indicated distance intervals.
The violin plots show the density of the distributions that resulted from the same analysis, but repeated 10 000× on HIV-1 genome sequences that were
randomized with preserving the local dinucleotide content; Predicted cleavage efficiency of (D) the sequence surrounding the 3′PPT, (E) of the terminal 18
nt of the tRNA-Lys3 primer and (F) it is reverse complement (primer binding site). (G) Predicted cleavage efficiency of the best-cleaved site in the terminal
18 nt of the different human tRNAs (plus CCA) and of the corresponding reverse complement. The tRNA-Lys3 is indicated in red.
cleave the sequence context CA↓AG, downstream of a
G-rich sequence. Moreover, these preferences significantly
correlate with the efficiency of antisense oligonucleotides
(ASOs) in cell culture, strongly suggesting that our results
can be used to improve their design. Interestingly, our find-
ings also explain previous anecdotal findings that ASOs
with the TCCCmotif (complementary to GGGA onRNA)
yielded more potent gene knockdown (42).
One of the limitations of the H-SPA method is the un-
natural structure of the probed substrates. For example,
the R4b construct contains both DNA and 2′-O-Me mod-
ified nucleotides in the cleaved strand, which will change
the structure compared to a conventional RNA–DNA
heteroduplex. Nevertheless, only one of the modified nu-
cleotides directly interacts with the RNase H1 enzyme (22)
(Supplementary Figure S8) and reassuringly, for the human
and E. coli RNase H, we obtained similar results with all
three constructs having differentmodification patterns (Fig-
ure 2A and Supplementary Figure S2a), suggesting that the
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different modifications in the substrates did not distort the
results.
HumanRNaseH1 has two nucleic acid binding domains:
the catalytic domain, which cleaves RNA and is structurally
similar to the E. coli RNase H1 (22,43,44) and the HBD,
which allows for the enzyme’s processive action (45).We ob-
serve strikingly similar sequence preferences of the human
and E. coli enzymes, indicating that in our experiments the
HBD did not affect the preferences of the human enzyme.
Thus, although we cannot rule out that HBD binding pref-
erences affect ASO efficiency in vivo, our results indicate
that the catalytic domain is central for human RNase H1
target preferences.
Interestingly, our results show that preferred sequences,
apart fromhaving a higher relative processing rate, also have
slower dissociation rate of the enzyme from the cleaved sub-
strate, which in some of our biochemical assays resulted in
the depletion of the active enzyme. Depending on the ex-
act cellular conditions these two counteracting mechanisms
will have opposite effects on the knockdown efficiency. It
has been reported that the concentration of RNase H is
a limiting factor to the antisense activity (46). Given the
relatively low copy number of majority of mRNAs in cells
(47), we do not expect the use of ASOs with RNase H pre-
ferred sequences will lead to substantial RNase H deple-
tion, which would suggest that taking the preferences of
RNaseH into account when designing ASOs sequences will
lead to more efficient cleavage for the large majority, if not
all mRNAs.
For the three RNase H enzymes we tested, the most pre-
ferred trinucleotide around the cleavage site is CA↓A,which
highlights the structural conservation of the catalytic center
(22). In contrast, we observed pronounced differences in the
preferences of HIV-1 and other tested RNases H upstream
from the cleavage site, with HIV-1 having a propensity to
cleave after GC-rich sequences, as opposed toG-rich for the
two other enzymes. Moreover, the sequence preferences of
the HIV-1 RNase H seem to differ fundamentally from the
human orE. coli enzymes for which the affinity for different
substrates can be understood as coming from a continuous
spectrum (29), allowing them to cleave all sequences albeit
with varying kinetics, whereas the viral enzyme can truly
discriminate between different substrates and prefers (C/G)
at−5, (C/G/U) at−4 and (C/G) at−2. The sequence pref-
erences that we observe for positions −5 to +2 agree with
the previously described preferences by Champoux and co-
workers (18,48–51). In these studies, additional significant
preferences were observed for positions −10 and −14 (18).
Because of the design of our R7 substrate with random-
ized positions not fully extending into the polymerase do-
main, these preferences and any other preferences that may
be present between positions −19 and −7 will not be de-
tected by our method. Future studies are needed to resolve
to what degree the polymerase domain dictates the overall
sequence preferences.
The difference in preferences between the HIV-1 and the
humanRNase H probably reflects the structural differences
of these two enzymes. The HIV-1 RNase H lacks the so-
called basic protrusion, which forms a DNA-binding chan-
nel in the human and E. coli enzyme and has an important
role in substrate binding (22) and it has been shown that
the HIV-1 RNase H activity depends on substrate binding
in the polymerase domain and is inactive in isolation (52).
Our R7 substrate is sufficiently long to simultaneously bind
both the HIV-1 polymerase and RNase H domains and is
efficiently cleaved in our experiments, indicating that the
constant dsDNA part of the R7 substrate binds the poly-
merase domain, even though a RNA–DNA heteroduplex
have been shown to bind with higher affinity to the poly-
merase domain than dsDNA (53). Possibly, the preference
for G or C in positions −2, −4 and −5 may be related to
the requirement of substrate untwisting in order to reach
the RNase H active site while simultaneously binding the
polymerase domain (54,55).
The R7 substrate used for the HIV-1 experiments dif-
fers from a typical HIV-1 RNase H substrate by having the
RNA–DNA hybrid region embedded within the long ds-
DNA structure. This is similar to the natural substrate af-
ter plus strand transfer when HIV-1 RNase H cleaves off
the tRNA primer (Figure 5B), but the large majority of
cleavages by HIV-1 RNase H during the viral lifecycle is
on DNA–RNA duplexes. We observe a preference for G
or C in RNA positions −5 and −6 relative to the scissile
phosphate. Those two positions are located at the border
of the DNA:DNA and RNA:DNA duplex of the R7 con-
struct and the helical conformation of this region is there-
fore likely to be more B-like than a pure RNA:DNA sub-
strate. This difference may influence the preference that we
observe, however, in a previous study with a limited set of
tested RNA–DNAduplexes, G has been reported to be pre-
ferred in position −5 (18). Additionally, in this region the
enzyme contacts exclusively the non-cleaved DNA strand,
which has the same sugar chemistry in our R7 substrate as
in the natural substrate (38,54).
The comprehensive nature of our analysis allowed us to
create a preference motif sufficiently rich in information
that we could perform global prediction of RNase H cleav-
age sites in theHIV genome.We correctly predict the known
cleavage sites, 5′of the PPT and the tRNAprimer (Figure 5E
and F), indicating that the identified preferences are biolog-
ically relevant. Interestingly, we not only found that our se-
quence preferences match the known cleavage of the tRNA-
Lys3 primer, but also that the reverse complement of the
tRNA-Lys3 sequence (PBS sequence) is effectively cleaved
by the HIV-1 RNase H, which may facilitate the DNA plus-
strand transfer during replication. Despite millions of years
of extremely rapid evolution (56) the same host molecule
(tRNA-Lys3) is utilized by almost all lentiviruses to prime
reverse transcription (35). A number of different mecha-
nisms likely contribute to the strong dependence of HIV-
1 on the tRNA-Lys3, such as: specific packaging of lysine
tRNAs (57,58) and interactions between the HIV-1 genome
and the TC arm of tRNA-Lys3 (59–61), hLysRS (62,63)
and the tRNA anticodon (64,65). We suggest that the effi-
cient Rnase H cleavage of tRNA-Lys3 and of the comple-
mentary PBS sequencemay also contribute to the conserved
use of tRNA-Lys3 as primer in HIV-1 replication.
During HIV-1 replication, cleavage of the HIV-1 RNA
genome occurs occasionally at a specific distance from the
growing DNA 3′ end to produce RNA oligomers of vari-
able length, some of which stay associated with the newly
synthesized DNA strand (66,67). Next, the RNA oligomers
Downloaded from https://academic.oup.com/nar/article-abstract/45/22/12932/4602871
by Faculty of Life Sciences Library user
on 02 February 2018
12942 Nucleic Acids Research, 2017, Vol. 45, No. 22
are further cleaved 13–19 nt from theRNA5′ end by aRNA
5′-end-directed mechanism (36,51). Previously, these end-
directed HIV-1 RNase H cleavage modes have been shown
to have sequence preferences very similar to the prefer-
ence of internal cleavage on longDNA–RNAduplexes (50).
Cleavage of the R7 substrate resembles the internal mode of
cleavage and we assume the observed preferences are rele-
vant also for HIV-1 RNases H end-directed cleavages. In
support of this, we find that HIV-1 genomic positions pre-
dicted by our cleavage model to be efficiently cleaved are
preferentially separated by 13–19 nt (Figure 5C). This find-
ing indicates that the HIV-1 genome is under selective pres-
sure for efficient processing by its own RNase H. Interest-
ingly, similar analysis performed for HIV-2 genome did not
show significant enrichment (Supplementary Figure S7b),
which may reflect that the role of viral RNase H in the re-
verse transcription of HIV-2 is less important, as indicated
by much lower RNase H activity (68). Finally, we note that
the two sites in the HIV-1 genome predicted to be the most
efficiently cleaved are located within the Rev response ele-
ment, suggesting a functional relevance.
In conclusion, this study uncovers sequence preferences
of the important RNase H enzymes and thereby provides
valuable information for the future design of antisense
oligonucleotides and contributes to an improved under-
standing of HIV-1 biology. The presented method, both ex-
perimental and computational, can be readily applied to
other enzymes acting on duplexed oligonucleotides, such as
the human RNase H2 or restriction endonucleases.
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